PHOENIX CHILDREN'S HOSPITAL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1983-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
38
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials
Ovarian Tissue Cryopreservation
- Conditions
- Infertility, Female
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Phoenix Children's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06710769
- Locations
- 🇺🇸
Phoenix Childrens, Phoenix, Arizona, United States
Benefits of Intrahospital Exercise Program in Pediatric HSCT
- Conditions
- Hematopoietic Stem Cell TransplantPediatric CancerDeconditioning
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Phoenix Children's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06692478
- Locations
- 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
A Clinical Trial of Soluble Fiber for Asthma
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Phoenix Children's Hospital
- Target Recruit Count
- 105
- Registration Number
- NCT06372249
- Locations
- 🇺🇸
Phoenix Children's, Phoenix, Arizona, United States
Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress
- Conditions
- Bronchopulmonary Dysplasia
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Phoenix Children's Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT05925075
- Locations
- 🇺🇸
Phoenix Children's, Phoenix, Arizona, United States
Oral Penicillin Challenge and Allergy De-labeling in Children
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Phoenix Children's Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT05563610
- Locations
- 🇺🇸
Phoenix Children's, Phoenix, Arizona, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
Anuncia Medical's ReFlow EVD Receives FDA Breakthrough Device Designation for Intracranial Pressure Management
Anuncia Medical has received FDA Breakthrough Device Designation for its ReFlow EVD, designed to manage brain swelling and elevated intracranial pressure through a novel noninvasive flushing mechanism.